Safety of anthrax vaccine: A review by the Anthrax Vaccine Expert Committee (AVEC) of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS)

Pharmacoepidemiology and Drug Safety

Volumn 11, Issue 3, 2002, Pages 189-202

  Sever, John L ^a,f   Brenner, Alan I ^b   Gale, Arnold D ^c   Lyle, Jerry M ^d   Moulton, Lawrence H ^e   West, David J ^d  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b Metro West Medical Center   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d George Washington University ^*  (United States)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^f GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

Anthrax vaccine; Vaccine Adverse Event Reporting System (VAERS); Vaccine safety

Indexed keywords

ANTHRAX VACCINE; DIPHENHYDRAMINE; DRUG; METHYLPREDNISOLONE; RANITIDINE; STEROID;

ACTIVE IMMUNIZATION; ADULT; ANAPHYLAXIS; ANTHRAX; ARTHRALGIA; ARTHRITIS; ARTICLE; BRONCHIOLITIS; CARDIOVASCULAR DISEASE; COMORBIDITY; CONTROLLED STUDY; CUBITAL TUNNEL SYNDROME; DELTOID MUSCLE; DISEASE SEVERITY; DOSE RESPONSE; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; FEMALE; FLU LIKE SYNDROME; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; INFLAMMATION; INFORMATION PROCESSING; INJECTION SITE; LICENSING; MAJOR CLINICAL STUDY; MALAISE; MALE; MORBIDITY; MUSCULOSKELETAL DISEASE; NEUROLOGIC DISEASE; ORGANIZING PNEUMONIA; PARESTHESIA; PHARMACOEPIDEMIOLOGY; PRIORITY JOURNAL; RASH; RESPIRATORY TRACT DISEASE; SOLDIER; SPONDYLOARTHROPATHY; SYSTEMIC DISEASE; TRICEPS BRACHII MUSCLE; UROGENITAL TRACT DISEASE; ADOLESCENT; EPIDEMIOLOGY; IMMUNOLOGY; POSTMARKETING SURVEILLANCE; REVIEW; UNITED STATES;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; ANTHRAX VACCINES; CAUSALITY; FEMALE; HUMAN; MALE; MILITARY PERSONNEL; PRODUCT SURVEILLANCE, POSTMARKETING; UNITED STATES; HUMANS;

EID: 0036001099     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/pds.712     Document Type: Article

References (35)

1. Bioterrorism alleging use of anthrax and interim guidelines for management-United States, 1998
2. Anthrax
3. Anthrax as a biological weapon. Medical and public health management
4. The specter of biological weapons
5. Iraq's biological weapons. The past as future?
6. Anthrax vaccine. Evidence for safety and efficacy against inhalational anthrax
7. Anthrax
8. Biologic products; Bacterial vaccines and toxoids; Implementation of efficacy review
9. Immunization studies with attenuated strains of Bacillus anthracis
10. Comparative efficacy of Bacillus anthracis live spore vaccine and protective antigen vaccine against anthrax in the guinea pig
11. Safety Review of Anthrax Vaccine
12. Field evaluation of a human anthrax vaccine
13. Repeated immunization: Possible adverse effects. Reevaluation of human subjects at 25 years
14. Surveillance for adverse events associated with anthrax vaccination
15. Vaccine adverse event reporting system-United States
16. An overview of the vaccine adverse event reporting system (VAERS) as a surveillance system
17. The complicated task of monitoring vaccine safety
18. Policy for Reporting Adverse Events Associated with the Anthrax Vaccine
19. Monitoring signals for vaccine safety: The assessment of individual adverse event reports by an expert advisory committee
20. Consensus methods for medical and health services research
21. Comparative safety of two recombinant hepatitis B vaccines in children: Data from the Vaccine Adverse Event Reporting System (VAERS) and Vaccine Safety Datalink (VSD)
22. Chronic multisymptom illness affecting Air Force veterans of the Gulf War
23. Voluntary Recall of Anthrax Vaccine Adsorbed
24. Anthrax vaccine: Immunogenicity and safety of a dose-reduction, route-change comparison study in humans
25. Intussusception among recipients of rotavirus vaccine - United States, 1998-1999
26. Intussusception among infants given an oral rotavirus vaccine
27. Withdrawal of rotavirus vaccine recommendation